CN101340897A - 兰索拉唑口腔崩解片剂 - Google Patents

兰索拉唑口腔崩解片剂 Download PDF

Info

Publication number
CN101340897A
CN101340897A CNA200580052347XA CN200580052347A CN101340897A CN 101340897 A CN101340897 A CN 101340897A CN A200580052347X A CNA200580052347X A CN A200580052347XA CN 200580052347 A CN200580052347 A CN 200580052347A CN 101340897 A CN101340897 A CN 101340897A
Authority
CN
China
Prior art keywords
tablet
oral cavity
cavity disintegration
sub
disintegration tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200580052347XA
Other languages
English (en)
Chinese (zh)
Inventor
D·I·西尔弗
L·阿里-帕多
S·安特勒
N·什特曼
S·迪卡普亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of CN101340897A publication Critical patent/CN101340897A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
CNA200580052347XA 2005-12-20 2005-12-20 兰索拉唑口腔崩解片剂 Pending CN101340897A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/046296 WO2007078271A2 (en) 2005-12-20 2005-12-20 Lansoprazole orally disintegrating tablets

Publications (1)

Publication Number Publication Date
CN101340897A true CN101340897A (zh) 2009-01-07

Family

ID=37672393

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200580052347XA Pending CN101340897A (zh) 2005-12-20 2005-12-20 兰索拉唑口腔崩解片剂

Country Status (5)

Country Link
JP (1) JP2009519334A (ja)
CN (1) CN101340897A (ja)
CA (1) CA2630235A1 (ja)
IL (1) IL191523A0 (ja)
WO (1) WO2007078271A2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101507718B (zh) * 2009-03-03 2011-05-04 张登科 雷贝拉唑钠肠溶口崩片及其制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR20100129761A (ko) * 2008-03-11 2010-12-09 다케다 야쿠힌 고교 가부시키가이샤 경구 붕해 고형 제제
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
SG190905A1 (en) * 2010-12-27 2013-07-31 Takeda Pharmaceutical Orally disintegrating tablet
CN102805737A (zh) * 2012-09-03 2012-12-05 海南中化联合制药工业股份有限公司 一种兰索拉唑肠溶口崩片及其制备方法
CN105392486A (zh) * 2013-05-21 2016-03-09 武田药品工业株式会社 口腔崩解片
US20170042806A1 (en) * 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
PT1736144E (pt) * 1998-05-18 2016-02-10 Takeda Pharmaceutical Comprimidos de desintegração oral
WO2004066982A1 (en) * 2003-01-31 2004-08-12 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and processes for their preparation
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2005046634A2 (de) * 2003-11-14 2005-05-26 Siegfried Generics International Ag Magensaftresistente verabreichungsform
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101507718B (zh) * 2009-03-03 2011-05-04 张登科 雷贝拉唑钠肠溶口崩片及其制备方法

Also Published As

Publication number Publication date
JP2009519334A (ja) 2009-05-14
WO2007078271A3 (en) 2007-10-11
IL191523A0 (en) 2008-12-29
CA2630235A1 (en) 2007-07-12
WO2007078271A2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
CN101340897A (zh) 兰索拉唑口腔崩解片剂
CN101378753A (zh) 兰索拉唑口崩片
EP2645996B1 (de) Verfahren zur herstellung einer ppi-haltigen pharmazeutischen zubereitung
ES2347968T3 (es) Preparacion solida que se disgrega rapidamente.
CA2323680C (en) Orally disintegrable tablets
EP1110544B1 (de) Verfahren zur Herstellung einer geschmacksmaskierten oralen Darreichungsform& x9;
RU2422135C2 (ru) Матричная таблетка с модифицированным высвобождением нерамексана
AU2010205684B2 (en) Active coating of pharmaceutical dosage forms
CN100352432C (zh) 含有那格列奈的制剂
EP2246052B1 (en) Orally rapidly disintegrating tablet comprising imidafenacin
WO2007074856A1 (ja) 口腔内崩壊性固形製剤の製造法
AU9268598A (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
CN106913553A (zh) 口腔崩解片及其制造方法
KR20110135870A (ko) 구강내 붕괴성 피복 정제
JP2010248106A (ja) フィルムコーティング錠
HU207948B (en) Process for producing oral pimobendane compositions
EA010972B1 (ru) Композиция, содержащая смесь активных начал, и способ ее получения
EP1813275A1 (en) Lansoprazole orally disintegrating tablets
JP2009524592A (ja) ランソプラゾール経口崩壊錠剤
JP3900245B2 (ja) 口腔内速崩壊型錠剤及びその製造方法
TW201811316A (zh) 加衣錠劑及彼之製法
JP5876418B2 (ja) 口腔内崩壊錠剤
CN1529587B (zh) 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物
EP3563846B1 (en) Pharmaceutical composition and method for producing the same
JP2010001242A (ja) レバミピド固形製剤及びその製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090107